Pharma Market Access Insights - from Mtech Access

58 Episodes

1. Market access and reimbursement in Canada – changes at CADTH

   Published: 6/20/2024
2. Rare Disease market access in the MENA and Nordic regions

   Published: 5/10/2024
3. How does funding flow in NHSE Regions?

   Published: 4/9/2024
4. NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024)

   Published: 4/9/2024
5. De-mystifying health economic model classifications and structures

   Published: 3/22/2024
6. Evidence strategy for Medical Technologies and Diagnostics

   Published: 3/12/2024
7. How to set your Pharma or Medtech product up for success in the US market

   Published: 2/26/2024
8. What's happening with specialised commissioning in the NHS?

   Published: 2/12/2024
9. Integrated care in NHS Wales – what can England learn from its neighbour?

   Published: 1/17/2024
10. Market access in Italy: Reforms at AIFA

    Published: 12/18/2023
11. Unmet need in NHS primary care – How can industry best support PCN leaders?

    Published: 11/28/2023
12. Population health management: a community effort across health and life sciences

    Published: 11/1/2023
13. Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access

    Published: 10/26/2023
14. 6 areas of UK health policy for Medtech to pay attention to

    Published: 10/16/2023
15. Market access in the German speaking markets

    Published: 8/29/2023
16. The role of nursing in driving digital change in the NHS

    Published: 7/26/2023
17. Market access for digital therapies and digital medicines

    Published: 7/19/2023
18. A global market access journey in cannabinoid pharmaceuticals

    Published: 6/17/2023
19. Primary Care and ICBs – what is the next step in the integration journey?

    Published: 5/15/2023
20. Data-led transformation in the NHS - partnering to optimise patient care

    Published: 3/31/2023